Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2006-12-19Effect of Probiotics on Systemic Inflammation and Insulin Resistance in Type 2 Diabetics and Healthy Controls
-
CLINICAL_TRIALS study record update · 2006-11-16Assessment of Insulin Sensitivity in Insulin-Resistant Subjects Fed Fish Protein
-
CLINICAL_TRIALS study record update · 2006-09-11A Randomized Controlled Trial Comparing the Effects of Two Education Strategies About Insulin on Preferences and Perceptions About Insulin Therapy
-
CLINICAL_TRIALS study record update · 2006-09-04ClinicalTrials.gov study NCT00371982
-
CLINICAL_TRIALS study record update · 2006-08-16Effect of Moderate Alcohol Consumption on PPAR-γ Activity and Risk Markers of Metabolic Disease: Influence of Genetic Variation in Alcohol Oxidation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2006-08-15Improving Control With Activity and Nutrition
-
CLINICAL_TRIALS study record update · 2006-08-09Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2006-08-07Effects of Angiotensin Type 1 Receptor Blockade With Losartan on Insulin Sensitivity and Secretion in Subjects With Type 2 Diabetes and Nephropathy
-
CLINICAL_TRIALS study record update · 2006-07-31Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2006-05-18Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria